Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on February 5, 2018, primarily announcing changes to its Board of Directors and executive compensation arrangements. Notably, board member Nicholas G. Moore announced his retirement, to be effective in May 2018. In his place, the company elected Jacqueline K. Barton, Ph.D., to the Board, assigning her to the Scientific Committee. This filing also details executive compensation for fiscal year 2017 and sets base salaries for 2018, along with significant equity awards granted in early 2018, including stock options and performance share units designed to align executive interests with shareholder returns and company revenue targets. The report also discloses personnel changes, including the upcoming transition of John C. Martin from Executive Chairman to Chairman of the Board and the departure of Kevin Young, Chief Operating Officer, in February 2018. The compensation committee approved accelerated vesting of certain equity awards for Mr. Young upon his separation. These updates provide insight into the company's governance and how it incentivizes its leadership team through compensation structures and strategic board appointments.
Key Highlights
- 1Nicholas G. Moore to retire from the Board of Directors in May 2018.
- 2Jacqueline K. Barton, Ph.D., appointed to the Board of Directors and its Scientific Committee.
- 3Details provided on 2017 bonus awards and 2018 base salaries for key executive officers.
- 4Significant 2018 equity awards granted to executive officers, including stock options and performance share units.
- 5Kevin Young, Chief Operating Officer, to separate from the company in February 2018.
- 6Accelerated vesting of certain equity awards approved for Kevin Young upon his departure.
- 7John C. Martin to transition from Executive Chairman to Chairman of the Board effective March 9, 2018.